Evidence map›Paper›PMID 42362665›Full record

ArticleScientific reports2026

Association of the combined atherosclerosis index of plasma and frailty index with arthritis in middle-aged and older adults: a cohort study.

Bo Chen, Xiangyi Li

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bo ChenDepartment of Orthopaedics, The Second People's Hospital of Changzhi City, Shanxi, China.
Xiangyi LiDepartment of Orthopaedics, The Second People's Hospital of Changzhi City, Shanxi, China. zyguke@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Atherogenic Index of Plasma (AIP) is a marker of atherosclerosis, and the Frailty Index (FI) reflects physiological decline. The combined effect of AIP and FI remains insufficiently studied. This study aimed to investigate the association between a combined AIP-FI measure and the risk of arthritis. This study utilized data from the China Health and Retirement Longitudinal Study (CHARLS) database between 2011 and 2020. A total of 4437 participants aged ≥ 45 years without arthritis at baseline were included. Cox proportional hazards regression models and restricted cubic spline (RCS) models were employed to explore the relationship between the AIP-FI and the risk of incident arthritis. Over a 10-year follow-up period, a total of 1470 participants developed arthritis, with an incidence rate of 33.13%. Cox regression analysis revealed that each 1-unit increase in AIP-FI was associated with a 3% increase in arthritis risk (HR = 1.03; 95% CI: 1.02 to 1.04). Participants in the highest tertile (T3) of AIP-FI had a 55% higher risk compared to those in the lowest tertile (T1) (HR = 1.55; 95% CI: 1.35 to 1.78). The RCS curve demonstrated a significant nonlinear positive association between AIP-FI and arthritis risk (P for overall < 0.001, P for nonlinear < 0.001). This study indicates that a higher AIP-FI is significantly associated with an increased risk of arthritis. By integrating metabolic and frailty data, the AIP-FI was associated with arthritis risk and may help identify older Chinese adults at higher risk. However, these findings require further validation in independent cohorts before any clinical consideration.

Indexed as

ArthritisAtherosclerosisFrailtyAgedBiomarkersChinaCohort StudiesFemaleHumansIncidenceLongitudinal StudiesMaleMiddle AgedProportional Hazards ModelsRisk FactorsBiomarkersArthritisAtherogenic index of plasmaCHARLSCohort studyFrailty index

Identifiers

PMID42362665
PMCPMC13570880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.